We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Kintor Pharmaceutical Limited is pleased to announce that the clinical trial of Proxalutamide's treatment of hospitalized COVID-19 patients was approved by the Institutional Review Board of Brazil.
Kintor Pharmaceutical Limited is pleased to update the preliminary analysis of the clinical trial of Proxalutamide for the treatment of COVID-19 patients.